Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model
Titel:
Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model
Auteur:
Perosky, Joseph E. Khoury, Basma M. Jenks, Terese N. Ward, Ferrous S. Cortright, Kai Meyer, Bethany Barton, David K. Sinder, Benjamin P. Marini, Joan C. Caird, Michelle S. Kozloff, Kenneth M.